Female Sexual Arousal Disorder
Clinical Trial Results Show Zestra for Women Overcomes Sexual Side Effects of SSRIs The Journal of Sex and Marital Therapy reported in its current issue positive findings of a randomized, double blind crossover trial designed to test the efficacy and safety of Zestra for Women. The botanical feminine massage oil, formulated to enhance female sexual pleasure and arousal, is the only non-prescription women's topical product supported by an FDA quality clinical trial. Zestra for Women also meets FDA qualifications and standards for cosmetic personal care products and massage oils.
Zestra was well tolerated among all women tested, including those suffering from Female Sexual Arousal Disorder (FSAD), and those without the condition. All women experienced improved levels of desire, satisfaction with level of sexual arousal, genital sensation, ability to reach orgasm, and overall enhanced sexual experiences. A major trial finding showed that Zestra for Women overcame the undesirable sexual side effects associated with SSRI antidepressants such as Paxil, Zoloft, Prozac, Celexa, Lexapro and other antidepressants in this category.
Zestra is a proprietary blend of all natural bioactive ingredients (Borage seed oil, Evening primrose oil, Angelica root extract, and Coleus extract) that function to increase genital sensory nerve conduction and genital blood flow. The enhancement of genital sensory nerve conduction by Zestra distinguishes it from other products that simply focus on increasing blood flow to the genitalia.
Zestra was designed, researched and developed over six years by pharmaceutical scientists and recognized women's sexual health experts. The bioactive botanical ingredients in Zestra were scientifically selected based on their synergistic abilities to increase female sexual sensation, arousal and pleasure through highly specific pathways in women.
Consumers should be aware that other topical products on the market for women utilize "known chemical irritants" such as: menthol, peppermint oil, cinnamon oil or oil of wintergreen and the effects they produce are merely "the result of clitoral and vaginal skin irritation". Furthermore, most of those products contain L-Arginine, which when applied topically, can potentially reactivate a latent herpes virus and therefore may cause genital herpes outbreaks in women who already have genital herpes. www.zestraforwomen.co.uk
